While researchers are grateful they can offer patients one of the two approved stabilizers, better therapeutics are still ...
Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
COVID-19 infection, compared with influenza, is associated with increased myocarditis rates among adults in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback